SUPERNUS PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Supernus Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $4M, a 15.8% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $12.9M, a 8.19% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $11.9M, a 71.4% increase from 2020.
  • Supernus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $6.95M, a 30.2% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $12.9M +$975K +8.19% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $11.9M +$4.96M +71.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $6.95M +$1.61M +30.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $5.34M Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.